Riskpilot← Back to searchSign inGet full accessMedovia VN AB
ABActiveOrg 5567734743StockholmRetail sale of pharmaceutical products · NACE 4773Est. 20080 employees
Revenue 2024
SEK 0
EBITDA margin
—
+33% vs 2023
Equity ratio
54.3%
Financial strength
Net profit 2024
SEK 683K
+19% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +33% |
| Net profit | SEK 683K | +19% |
| Total assets | SEK 1,6M | -95% |
| Equity | SEK 857K | -97% |
| Employees | 0 | — |
Legal name
Medovia VN AB
Org number
5567734743
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
18 december 2008
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall direkt eller indirekt bedriva apoteksverksamhet och därmed förenlig verksamhet.
Address
Stockholm
Phone
+46101010222
Email
info@medovia.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 38 556 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 8 279 | −1 434 | −1 904 | −3 | −2 |
| Depreciation & amort. | −110 | −0 | −0 | −0 | −0 |
| EBIT | 8 169 | −1 434 | −1 904 | −3 | −2 |
| Net financials | −4 | −22 | 46 | 936 | 1 031 |
| Profit before tax | 34 247 | −17 | −176 | 713 | 814 |
| Tax | −7 516 | −3 | −0 | −138 | −131 |
| Net profit | 26 731 | −20 | −176 | 575 | 683 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 44 922 | 37 976 | 31 549 | 32 475 | 1 578 |
| Equity | 31 696 | 31 675 | 31 499 | 32 074 | 857 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 13 226 | 6 300 | 50 | 181 | 286 |
| Total debt | 13 226 | 6 300 | 50 | 181 | 286 |
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
20202024
Equity ratio
54.3%
This company
38.2%
Market median
+42% vs market
20202024
Return on equity
79.7%
This company
18.4%
Market median
+333% vs market
20202024
Net profit margin
68300000.0%
This company
8.1%
Market median
+843209777% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OJ Chief Auditor | Chief Auditor | 2022 |
| Former (3) | ||
KJ Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
PG Audit | Audit | 2020 – 2022 |
JM Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medovia AB
Medovia VN AB Board members of Medovia VN AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Johan Möller | Chief Executive Officer | 0 companies |
| Per Göran Mattis | Audit | 0 companies |
| Jens Martin Bernstone | Chief Auditor | 0 companies |
| Olof Johannes Nordgaard | Chief Auditor | 0 companies |
| John Patrick Berlips | Deputy Board Member | 0 companies |
| Jens-Leo Hubertus Berlips | Deputy Board Member | 0 companies |
| Lars Jonas Högdahl | Deputy Board Member | 0 companies |
| Peter Olof Elmquist | Board of Directors | 0 companies |